Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on Clearside Biomedical, Maintains $5 Price Target

Needham analyst Serge Belanger reiterates Clearside Biomedical (NASDAQ:CLSD) with a Buy and maintains $5 price target.

byBenzinga Newsdesk

February 3, 2023

1 minute read

Needham analyst Serge Belanger reiterates Clearside Biomedical (NASDAQ:CLSD) with a Buy and maintains $5 price target.

Analyst Ratings

Expert Ratings For Valero Energy

By Benzinga Insights

Today, 2:59 AM

Analysts have provided the following ratings for Valero Energy (NYSE:VLO) within the last quarter:

VLO

DA Davidson Maintains Buy on Aurora Innovation, Raises Price Target to $14.25

By Benzinga Newsdesk

Today, 2:59 AM

DA Davidson analyst Tom White maintains Aurora Innovation (NASDAQ:AUR) with a Buy and raises the price target from $13 to $14.25.

AUR

Post Holdings Q1 Adj. EBITDA $69M, Sales $1.52B Miss $1.64B Estimate

By Benzinga Newsdesk

Today, 2:59 AM

Post Holdings (NYSE:POST) reported quarterly sales of $1.52 billion which missed the analyst consensus estimate of $1.64 billion by 7.32 percent. This is a 4.25 percent increase over sales of $1.46 billion the same

POST

News

Boeing Says 787 Fuselages Are Not Transported By Rail, So Wouldn’t Be Affected By A Possible Rail Shutdown

By Benzinga Newsdesk

Today, 2:59 AM

- Reuters

Needham Reiterates Buy on Clearside Biomedical, Maintains $5 Price Target

Related Posts

Expert Ratings For Valero Energy

DA Davidson Maintains Buy on Aurora Innovation, Raises Price Target to $14.25

Post Holdings Q1 Adj. EBITDA $69M, Sales $1.52B Miss $1.64B Estimate

Boeing Says 787 Fuselages Are Not Transported By Rail, So Wouldn’t Be Affected By A Possible Rail Shutdown